| Correlation between pretreatment neutrophil-to-lymphocyte ratio and programmed death-ligand 1 expression as prognostic markers in non-small cell lung cancer CF Pirlog, HT Cotan, A Parosanu, CO Slavu, AM Popa, C Iaciu, M Olaru, ... Cureus 14 (7), 2022 | 7 | 2022 |
| Systemic neutrophil-to-lymphocyte ratio as a prognostic biomarker for colon cancer CI Iaciu, RA Emilescu, HT Cotan, C Nitipir Chirurgia (Bucur) 118 (3), 260-71, 2023 | 6 | 2023 |
| Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature CF Pîrlog, AI Paroșanu, CO Slavu, M Olaru, AM Popa, C Iaciu, I Niță, ... Current Oncology 29 (12), 9428-9436, 2022 | 6 | 2022 |
| The prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma AI Parosanu, CF Pirlog, CO Slavu, IM Stanciu, HT Cotan, RC Vrabie, ... Current Oncology 30 (2), 2457-2464, 2023 | 4 | 2023 |
| Rituximab-induced Kaposi sarcoma in HIV-negative patients: a narrative review A Oprita, H Cotan, D Celmare, R Emilescu Cureus 15 (9), 2023 | 2 | 2023 |
| Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? CF Pîrlog, R Costache, AI Paroșanu, CO Slavu, M Olaru, AM Popa, ... Diagnostics 13 (11), 1892, 2023 | 2 | 2023 |
| Desensitization protocol to carboplatin: a technical report C Nitipir, A Parosanu, AM Popa, H Cotan, M Olaru, C Iaciu, CO Slavu Cureus 14 (4), 2022 | 2 | 2022 |
| Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy A Parosanu, IM Stanciu, C Pirlog, CO Slavu, H Cotan, C Iaciu, AM Popa, ... Cureus 14 (10), 2022 | 1 | 2022 |
| The Prognostic Implications of Synchronous Cancers in Breast Cancer Patients A Oprita, H Cotan, C Nitipir Cureus 16 (9), 2024 | | 2024 |
| Role of the Modified Glasgow Prognostic Score (mGPS) as a Prognostic Factor in Metastatic Colorectal Cancer H Cotan, C Iaciu, C Nitipir Cureus 16 (7), 2024 | | 2024 |
| Gustave Roussy Immune Score (GRIm-Score) as a Prognostic and Predictive Score in Metastatic Colorectal Cancer H Cotan, C Iaciu, E Radu, T Niculae, OA Rosu, C Nitipir Cureus 16 (4), 2024 | | 2024 |
| Challenges in the Diagnosis and Treatment of Oral Amelanotic Malignant Melanoma: A Case Report OA Rosu, MI Tolea, AI Parosanu, MI Stanciu, HT Cotan, C Nitipir Cureus 16 (4), 2024 | | 2024 |
| The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer A Lazar, AM Popa, C Orlov-Slavu, HT Cotan, CI Iaciu, CM Olaru, ... Medicina 60 (8), 1290, 2024 | | 2024 |
| The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis RA Emilescu, M Jinga, HT Cotan, AM Popa, CM Orlov-Slavu, MC Olaru, ... International Journal of Molecular Sciences 24 (23), 16930, 2023 | | 2023 |
| Role of Systemic Inflammation Markers in Colorectal Cancer Prognosis-A Narrative Review CI Iaciu, RA Emilescu, HT Cotan, C Orlov, AC Popa, C Nitipir Clin Case Rep Int. 2023; 7 1551, 2023 | | 2023 |
| Prognostic Factors in First-line Metastatic Renal Cell Carcinoma: How to Improve the Prognostic Ability of the IMDC and MSKCC Score? A Parosanu, M Stanciu, C Parlog, C Orlov, M Olaru, AM Popa, H Cotan, ... International Journal of Innovative Research in Medical Science (IJIRMS) 7 (12), 2022 | | 2022 |
| Actualităţi in diagnosticul și tratamentul neoplaziilor avansate din sfera genitală-utilitatea testelor de tip Next Generation Sequencing. C Niţipir, M Stanciu, M Olaru, AM Popa, IC Iaciu, C Pârlog, I Niţă, H Cotan, ... Romanian Journal of Family Medicine/Revista Română de Medicina Familiei 5 (2), 2022 | | 2022 |
| Neurological Paraneoplastic Syndromes: the Early Diagnosis of Lung Cancer A PAROSANU, AM POPA, C IACIU, M OLARU, C ORLOV-SLAVU, ... Modern Medicine 29 (1), 2022 | | 2022 |
